Tag: omalizumab Xolair

All

The treatment yielded similar outcomes for egg, milk, wheat, cashew, walnut, and hazelnut.

Genentech announced that the FDA has approved Xolair to treat moderate to severe persistent asthma in specific children 6 to 11 years of age.